Related Experiment Video
Updated: Aug 19, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Understanding the role of Cripto-1 in cancer progression and therapeutic strategies
Qingfang Zeng1, Yuzhen Gao2, Ying Zhou3
1Department of Gastroenterology, The 910 Hospital of Joint Logistic, Support Force Hua-Yuan Road No.180, Quanzhou City, Fujian Province, 362000, China.
Abstract:
During the initial stages of gastrulation during embryonic differentiation and wound healing, Cripto-1 is a critical protein for human growth. The epithelial adhesion molecules' downregulation, the mesenchymal overexpression, and mobile proteins are important mechanisms by which Cripto-1 initiates epithelial to mesenchymal transition (EMT). As a result, the function of Cripto-1 for inducing EMT to increase cell migration is advantageous during embryogenesis; however, it is deleterious during the formation, growth, and malignant tumor metastasis. The majority of malignancies are reported to have elevated levels of Cripto-1. Cripto-1 can modify cancerous cells through its function in EMT, which enables these cells to migrate via the extracellular matrix, bloodstream, and lymphatic vessels, on their way for metastasizing to other organs. The goal of this review is to explain what role Cripto-1 plays in common cancers and to summarize how therapeutic strategies are used to interfere with this molecule to target cancers.
Insights
Cripto-1 protein drives human growth but promotes cancer metastasis by initiating epithelial to mesenchymal transition (EMT). This review explores Cripto-1
Area of Science:
- Developmental Biology
- Cancer Biology
- Molecular Oncology
Background:
- Cripto-1 is a crucial protein in embryonic development, regulating epithelial to mesenchymal transition (EMT).
- Elevated Cripto-1 levels are observed in most malignancies, correlating with tumor progression.
- Cripto-1 facilitates cell migration and metastasis by inducing EMT.
Purpose of the Study:
- To elucidate the role of Cripto-1 in common human cancers.
- To review therapeutic strategies targeting Cripto-1 for cancer treatment.
Main Methods:
- Review of existing literature on Cripto-1 function in embryogenesis and cancer.
- Analysis of Cripto-1's mechanisms in promoting epithelial to mesenchymal transition (EMT).
- Summary of therapeutic interventions aimed at inhibiting Cripto-1 activity.
Main Results:
- Cripto-1's dual role: essential for embryonic growth but detrimental in cancer metastasis.
- Cripto-1 facilitates cancer cell migration through EMT, enabling invasion and spread.
- High Cripto-1 expression is a hallmark of many malignant tumors.
Conclusions:
- Cripto-1 is a significant factor in cancer progression and metastasis.
- Targeting Cripto-1 offers a promising therapeutic avenue for various cancers.
- Further research into Cripto-1-based therapies is warranted.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

